Introduction to preimplantation genetic diagnosis

Preimplantation Genetic Diagnosis, Second Edition

Volumn , Issue , 2009, Pages 1-47

  Harper, Joyce C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959346239     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511581571.002     Document Type: Chapter

References (118)

1. Aboulghar MA, Mansour RT, Serour GI et al. Oocyte quality in patients with severe ovarian hyperstimulation syndrome. Fertilityand Sterility 1997; 68:1017-21.
2. Abusheika N, Lass A, Akagbosu F and Brinsden P. How useful is cervical dilatation in patients with cervical stenosis who are participating in an in vitro fertilization-embryo transfer program? tte Bourn Hall experience. Fertility and Sterility 1999; 72: 610-12.
3. Adams J and Franks S. Multifollicular ovaries: clinical and endocrinological features and response to pulsatile gonadotrophin releasing hormone. Lancet 1985; 2: 1375-8.
4. Akman MA, Erden HF, Tosun SB et al. Addition of GnRH antagonist in cycles of poor responders undergoing IVF. Human Reproduction 2000; 15: 2145-7.
5. Akman MA, Erden HF, Tosun SB et al. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Human Reproduction 2001; 16: 868-70.
6. Bancsi LF, Huijs AM, Den Ouden CT et al. Basal follicle- stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertility and Sterility 2000; 73: 552-7.
7. Bean CJ, Hassold TJ, Judis L and Hunt PA. Fertilization in vitro increases non-disjunction during early cleavage divisions in a mouse model system. Human Reproduction 2002; 17(9): 2362-7.
8. Bonduelle M, Liebaers I, Deketelaere V, Derde M-P, Camus M, Devroey P and Van Steirteghem A. Neonatal data on a cohort of2889 infants born after ICSI (1991-1999) and of 1995 infants born after IVF (1983-1999). Human 67 Reproduction 2002; 17: 671-94.
9. Broekmans FJ, Kwee J, Hendriks DJ et al. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update2006; 12: 685-718.
10. Bukman A and Heineman MJ. Ovarian reserve testing and the use of prognostic models in women with subfertility. Human Reproduction Update 2001; 7: 581-90.
11. Camus E, Poncelet C, Goffnet F, Wainer B, Merlet F, Nisand I and Philippe HJ. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. HumanReproduction 1999; 14: 1243-9.
12. Casper RF. Ovarian hyperstimulation: effects of Gn RH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome? Human Reproduction 1996; 11: 1144-6.
13. Cedrin-Durnerin I, Bstandig B, Herve F et al. A comparative study of high fixed-dose and detrimental-dose regimens of gonadotrophins in a minidose gonadotrophin releasing hormone agonist flare protocol for poor responders. Fertility and Sterility 2000; 73: 1055-6.
14. Chang MY, Chiang CH, Hsieh TT et al. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertility and Sterility 1998; 69: 505-10.
15. Cohen J, Gilligan A, Esposito W, Schimmel T and Dale B. Ambient air and its potential effects on conception in vitro. Human Reproduction 1997; 12(8): 1742-9.
16. Collins J, Burrows EA and Willan AR. The prognosis forlive birth among untreated infertile couples. Fertility and Sterility 1995; 64: 22-8.
17. Conway GS, Payne NN, Webb J, Murray A and Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Human Reproduction 1998; 13: 1184-7.
18. Craft I, Gorgy A, Hill J et al. Will GnRH antagonistsprovide new hope for patients considered difficult responders to GnRH agonist protocols? Human Reproduction 1999; 14: 2959-62.
19. Crosignani PG, Ragni G, Lombroso GC et al. IVF: induction of ovulation in poor responders. Journal of Steroid Biochemistry and Molecular Biology 1989; 32:171-3.
20. de Kroon CD and Jansen FW. Saline infusion sonography in women with abnormal uterine bleeding: an update of recent findings. Current Opinion in Obstetrics and Gynecology 2006; 18 (6): 653-7.
21. Deaton J, Baugness P, Huffman C and Miller K. Pituitary response to early follicular phase minidose gonadotropin releasing hormone agonist (GnRH-a) therapy: evidence for a second flare. Journal of Assisted Reproduction and Genetics 1996; 13: 390-4.
22. Demirol A and Gurgan T. Effect of treatment of intrauterine pathologies with office hysteroscopy in patients with 68 recurrent IVF failure. Reproductive Biomedicine Online 2004; 8(5): 590-4.
23. de Mendoza MV, Gonzalez-Utor AL, Cruz N, Gutierrez P, Cascales F and Sillero JM. In situ use of pentoxifylline to assess sperm vitality in intracytoplasmic sperm injection for treatment of patients with total lack of sperm movement. Fertilityand Sterility 2000; 74(1): 176-7.
24. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage, and distribution of human tissues and cells. Official Journal ofthe European Union, L102, 48-58.
25. Dirnfeld M, Fruchter O, Yshai D et al. Cessation of gonadotropin-releasing hormone analogue (GnRHa) upon down-regulation versus conventional long GnRH - a protocol in poor responders undergoing in vitro fertilization. Fertility and Sterility 1999; 72: 406-11.
26. Donnez J, Wyns C andNisolle M. Does ovarian surgery for endometriomas impair the ovarian response to gonadotropin? FertilityandSterility 2001; 76: 662-5.
27. Dumoulin JC, Vanvuchelen RC, Land JA, Pieters MH, Geraedts JP and Evers JL. Effect of oxygen concentration on in vitro fertilization and embryo culture in the human and the mouse. Fertility and Sterility 1995; 63(1): 115-19.
28. Edwards RG. Human implantation: the last barrier in assisted reproduction technologies? Reproductive Biomedicine Online 2006; 13: 887-904.
29. Egbase PE, Al-Sharhan M and Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Human Reproduction 2000; 15: 1943-6.
30. Escriba MJ, Zulategui JF, Galan A, Mercader A, Remohi J and de los Santos MJ. Vitrification of preimplantation genetically diagnosed human blastocysts and its contribution to the cumulative ongoing pregnancy rate per cycle by using a closed device. Fertility and Sterility 2008; 89(4): 840-6.
31. ESHRE Task Force on Intracytoplasmic Sperm Injection. Assisted reproduction by intracytoplasmic sperm injection: a survey on the clinical experience in 1994 and the children born after ICSI, carried out until 31 December 1993. Human Reproduction 1998; 13(6):1737-46.
32. Faber BM, Mayer J, Cox B et al. Cessation of gonadotrophin- releasing hormone agonist therapy combined with high-dose gonadotrophin stimulation yields favorable pregnancy results in low responders. Fertility and Sterility 1998; 69: 826-30.
33. Fahri J, Homburg R, Ferber A, Orvieto R and Ben Rafael Z. Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Human Reproduction 1997; 12: 241-3.
34. Fischer B and Bavister BD. Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. Journal of Reproduction and Fertility 1993; 99(2): 673-9.
35. Frattarelli JL, Lauria-Costab DF, Miller BT et al. Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles. Fertility and Sterility 2000; 74:512-17.
36. Garcia-Velasco JA, Isaza V, Requena A et al. High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Human Reproduction 2000; 15: 2292-6.
37. Gardner DK, Rodriegez-Martinez H and Lane M. Fetal development after transfer is increased by replacing protein with the glycosaminoglycan hyaluronan for mouse embryo culture and transfer. Human Reproduction 1999; 14(10): 2575-80.
38. Gardner DK, Lane M. Physiology and culture of the human blastocyst. Journal of Reproduction and Immunology 2002; 55(1-2): 85-100.
39. Garello C, Baker H, Rai J, Montgomery S, Wilson P, Kennedy CR and Hartshorne GM. Pronuclear orientation, polar body placement, and embryo quality after intracytoplasmic sperm injection and in-vitro fertilization: further evidence for polarity in human oocytes? Human Reproduction 1999; 14(10): 2588-95.
40. Gerris J, De Vits A, Joostensm M et al. Triggering of ovulation in human menopausal gonadotrophin stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10 000 IU). Human Reproduction 1995; 10: 56-62.
41. Gianaroli L, Magli MC, Ferraretti AP, Fortini D and Grieco N. Pronuclear morphology and chromosomal abnormalities as scoring criteria for embryo selection. Fertility and Sterility 2003; 80(2): 341-9.
42. Giles JR and Foote RH. Effects of gas atmosphere, platelet- derived growth factor and leukemia inhibitory factor on cell numbers of rabbit embryos cultured in a protein- free medium. Reproduction, Nutrition, Development 1997; 37(1): 97-104.
43. Goudas VT, Hammitt DG, Damario MA, Session DR, Singh AP and Dumesic DA. Blood on the embryo transfer catheter is associated with decreased rates of embryo implantation and clinical pregnancy with the use of in vitro fertilization-embryo transfer. Fertility and Sterility 1998; 70: 878-82.
44. Goker EN, Sendag F, Levi R, Sen dag H and Tavmergen E. Comparison of the ICSI outcome of ejaculated sperm with normal, abnormal parameters and testicular sperm. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2002; 104(2): 129-36.
45. Groutz A, Lessing JB, Wolf Y, Yovel I, Azem F and Amit A. Cervical dilatation during ovum pick-up in patients with cervical stenosis: effect on pregnancy outcome in an in vitro fertilization-embryo transfer program. Ferility and Sterility 1997; 67: 909-11.
46. Gulekli B, Bulbul Y, Onvural A et al. Accuracy of ovarian reserve tests. Human Reproduction 1999; 14: 2822-6.
47. Harper JC, de Die-Smulders C, Goossens V et al. ESHRE PGD Consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Human Reproduction 2008; 23(4): 741-55.
48. Hazout A, de Ziegler D, Cornel C, Fernandez H, Lelaidier C and Frydman R. Comparison of short 7-day and prolonged treatment with gonadotropin-releasing hormone against desensitization for controlled ovarian hyperstimulation. Fertility and Sterility 1993; 59: 596-600.
49. Hendriks DJ, Mol BW, Bancsi LF et al. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. FertilityandSterility 2005; 83:291-301.
50. Hofmann G, Toner J, Muasher S and Jones G. High-dose follicle stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. Journal of In Vitro Fertilization and Embryo Transfer 1989; 6:285-9.
51. Howies CM, Macnamee MC and Edwards RG. Short term use of an LHRH agonist to treat poor responders entering an IVF programme. Human Reproduction 1987; 2: 655-6.
52. Hugues JN, Torresani T, Herve F et al. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotrophins in poor responder women. Fertility and Sterility 1991; 55: 945-51.
53. Hull MG. Epidemiology of polycystic ovarian disease: endocrinological and demographic studies. Gynaecological Endocrinology 1987; 1: 235-59.
54. Human Fertilisation and Embryology Authority (HFEA).Code of Practice, seventh edition. London: HFEA, 2007.
55. Kahraman S, Kumtepe Y, Sertyel S et al. Pronuclear morphology scoring and chromosomal status of embryos in severe male infertility. Human Reproduction 2002; 17(12): 3193-200.
56. Karan de V, Jones G, Veeck L and Muasher S. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertility and Sterility 1990; 53: 486-9.
57. Karan de V and Gleicher N. A rational approach to the management of low responders in IVF. Human Reproduction 1999; 14:1744-9.
58. Karande VC, Morris R, Chapman C, Rinehart J and Gleicher N. Impact of the “physician factor” on pregnancy ratesin a large assisted reproductive technology program: do too many cooks spoil the broth? Fertility and Sterility 1999; 71: 1001-9.
59. Kline J, Kinney A, Kelly A et al. Predictors of antral follicle count in reproductive years. Human Reproduction 2005; 20:2179-89.
60. Kovacic B, Vlaisavljevic V and Reljic M. Clinical use of pentoxifylline for activation of immotile testicular sperm before ICSI in patients with azoospermia. Journal of Andrology 2006; 27(1): 45-52.
61. Kurinczuk JJ and Bower C. Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation. British Medical Journal 1997; 315: 1260-6.
62. Kuwayama M, Vajta G, Ieda S and Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reproductive Biomedicine Online 2005; 11:608-14.
63. La Marca A, Giulini S, Orvieto R et al. Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Human Reproduction 2005; 20:1569-72.
64. Lee SJ, Lenton EA, Sexton L et al. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Human Reproduction 1988; 7: 851-5.
65. Leondires MP, Escalpes M, Segars JH et al. Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertility and Sterility 1999; 72: 1018-23.
66. Licciardi FL, Liu HC and Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertility and Sterility 1995; 64: 991-4.
67. Magarelli PC, Pearlstone AC and Buyalos RP. Discrimination between chronological and ovarian age in infertile women aged 35 and over: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/intrauterine insemination cycles. Human Reproduction 1996; 11: 1214-19.
68. Mansour R, Aboulghar M and Senour G. Dummy embryo transfer: a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization. Fertility and Sterility 1990; 54: 678-81.
69. Marcoux S, Maheux R and Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on endometriosis. New England Journal of Medicine 1997; 337:217-22.
70. Montag M and van der Ven H. German Pronuclear Morphology Study Group. Evaluation of pronuclear morphology as the only selection criterion for further embryo culture and transfer: results of a prospective multicentre study. Human Reproduction 2001; 16(11): 2384-9.
71. Moon JH, Hyun CS, Lee SW, Son WY, Yoon SH and Lim JH. Visualization of the metaphase II meiotic spindle in living human oocytes using the Polscope enables the prediction of embryonic developmental competence after ICSI. Human Reproduction 2003; 18(4): 817-20.
72. Muasher SJ, Oehninger S, Simonetti S et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertility and Sterility 1988; 50: 298-307.
73. Munne S and Cohen J. Chromosome abnormalities in human embryos. Human Reproduction Update 1998; 4(6): 842-55.
74. Muttukrishna S, McGarrigle H, Wakin R et al. Antral follicle count, anti-mullerian hormone and inhibin B: Predictors of ovarian response in assisted reproductive technology? BJOG 2005; 112:1384-90.
75. Ng EH, Tang OS and Ho PC. The significance of the number of antral follicles prior to stimulation in predicting ovarian responses in an IVF programme. Human Reproduction 2000; 15:1937-42.
76. Oehninger S, Brzyski RG, Muasher SJ, Acosta AA and Jones GS. In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist. Human Reproduction 1989; 4(5): 541-4.
77. Oh SJ, Gong SP, Lee ST, Lee EJ and Lim JM. Light intensity and wavelength during embryo manipulation are important factors for maintaining viability of preimplantation embryos in vitro. Fertility and Sterility 2007; 88(4 Suppl.): 1150-7.
78. Orsi NM and Leese HJ. Protection against reactive oxygen species during mouse preimplantation embryo development: role of EDTA, oxygen tension, catalase, superoxide dismutase and pyruvate. Molecular Reproduction and Development 2001; 59(1): 44-53.
79. Padilla S, Dugan K, Maruschak V et al. Use of the flare-up protocol with high dose follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertility and Sterility 1996; 65:796-9.
80. Palermo G, Joris H, Devroey P and Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992; 340(8810): 17-18.
81. Parriego M, Sole M, Aurell R, Barri PN and Veiga A. Birth after transfer of frozen-thawed vitrified biopsied blastocysts. Journal of Assisted Reproduction and Genetics 2007; 24(4): 147-9.
82. Perez-Medina T. Endometrial polyps and their implication in the pregnancy rates of patients undergoingintrauterine insemination: a prospective, randomised study. Human Reproduction 2005; 20(6): 1632-5.
83. Rall WF and Fahy GM. Ice-free cryopreservation of mouse embryos at -196 degrees C by vitrification. Nature 1985; 313(6003): 573-5.
84. Rama Raju GA, Prakash GJ, Krishna KM and Madan K. Meiotic spindle and zona pellucida characteristics as predictors of embryonic development: a preliminary study using PolScope imaging. Reproductive Biomedicine Online 2007; 14(2): 166-74.
85. Ranieri DM, Quinn F, Makhlouf A et al. Simultaneous evaluation of basal follicle stimulating hormone and 17 Beta estradiol response to gonadotrophin releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertility and Sterility 1998; 70: 227-33.
86. Ranieri DM, Phophong P, Khadum I et al. Simultaneous evaluation of basal FSH and oestradiol response to GnRH analogue (F-G-test) allows effective drug regime selection in IVF. Human Reproduction 2001; 16: 673-75.
87. Sathananthan AH, Kola I, Osborne J etal. Centrioles in the beginning of human development. Proceedings of the National Academy of Sciences of the United States of America 1991; 88(11): 4806-10.
88. Schachter M, Friedler S, Raziel A et al. Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotrophin stimulation phase - a function of improved embryo quality. Journal of Assisted Reproduction and Genetics 2001; 18: 197-204.
89. Scheffer GJ, Broekmans FJM, Dorland M et al. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertility and Sterility 1999; 72: 845-51.
90. Schlenker T, Gee M et al. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle- stimulating hormone flare, growth hormone protocol. Fertility and Sterility 1997; 67: 93-7.
91. Schoolcraft W et al. Increasedhyaluronan concentration in the embryo transfer medium results in a significant increase in human embryo implantation rate. American Society for Reproductive Medicine 2002. Seattle, USA. (abstract).
92. Schumacher A and Fischer B. Influence of visible light and room temperature on cell proliferation in preimplantation rabbit embryos. Journal of Reproduction and Fertility 1988; 84(1): 197-204.
93. Scott LA and Smith S. Hie successful use of pronuclear embryo transfers the day following oocyte retrieval. Human Reproduction 1998; 13(4): 1003-13.
94. Scott R, Carey K, Leland M and Navot D. Gonadotropin responsiveness to ultra low-dose leuprolide acetate in baboons. Fertility and Sterility 1993; 59:1124-8.
95. Scott RT, Toner JP, Muasher SJ et al. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertility and Sterility 1989; 51: 651-4.
96. Scott RT and Hoffman GE. Prognostic assessment of ovarian reserve. Fertility and Sterility 1995; 63: 1-11.
97. Seifer DB, MacLaughlin DT, Christian BP et al. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertility and Sterility 2002; 77:468-71.
98. Serhal P, Ranjeri DM, Khadum I et al. Cervical dilatation with hygroscopic rods prior to ovarian stimulation facilitates embryo transfer. Human Reproduction 2003; 18(12): 2618-20.
99. Serhal PF, Katz M, Little V and Woronowski H. Unexplained infertility - the value of Pergonal superovulation combined with intrauterine insemination. Fertility and Sterility 1988; 49: 602-6.
100. Sharif K, Elgendy M, Lashen H et al. Age and basal follicle stimulating hormone as predictors of in vitro fertilization outcome. British Journal of Obstetrics and Gynaecology 1998; 105: 107-12.
101. Smotrich DB, Widra EA, Gindorff PR et al. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertility and Sterility 1995; 64:1136-40.
102. Society for Assisted Reproductive Technology (SART)/American Society for Reproductive Medicine (ASRM). Assisted reproductive technology in the United States and Canada: 1993 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertility and Sterility 1995; 64(1): 13-21.
103. Steptoe PC and Edwards RG. Birth afterthe re-implantation of a human embryo (letter). Lancet 1978; 2: 366.
104. Strandell A, Lindhard A, Waldenstrom U, Hiornburn J, Janson PO and Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Human Reproduction 1999; 14:2762-9.
105. Tanbo T, Dale PO, Ludne O et al. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated hormone levels. Fertility and Sterility 1992; 57: 819-24.
106. Takenaka M, Horiuchi T and Yanagimachi R. Effects of light on development of mammalian zygotes. Proceedings of the National Academy of Sciences of the United States of America 2007; 104(36): 14289-93.
107. Tesarik J and Greco E. Hie probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology. HumanReproduction 1999; 14(5): 1318-23.
108. Toner JP, Philput CB, Jones GS et al. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertility and 71 Sterility 1991; 55: 784-91.
109. Toth T, Awwad J, Veeck L et al. Suppression and flare regimens of gonadotropin-releasing hormone agonist: use in women with different basal gonadotropin values in an in vitro fertilization program. Journal of Reproductive Medicine 1996; 41: 321-6.
110. Ulug U, Bahceci M, Erden HF et al. The significance of coasting duration during ovarian stimulation for conception in assisted fertilisation cycles. Human Reproduction 2002; 17: 310-13.
111. Vandervorst M, Liebaers I and Sermon K. Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Human Reproduction 1998; 13: 3169-79.
112. Van HooffMH, Alberda AT, Huisman GJ etal. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Human Reproduction 1993; 8:369-73.
113. van Rooij IA, Broekmans FJ, te Velde ER et al. Serum anti- Mullerian hormone levels: a novel measure of ovarian reserve. Human Reproduction 2002; 17: 3065-71.
114. Visser DS, Fourie FL and Kruger HF. Multiple attempts at embryo transfer: effect on pregnancy outsome in an in vitro fertilization and embryo transfer program. Journal of Assisted Reproduction and Genetics 1993; 10: 37-43.
115. Wang WH, Meng L, Hackett RJ and Keefe DL. Developmental ability of human oocytes with or without birefringent spindles imaged by Polscope before insemination. Human Reproduction 2001; 16(7): 1464-8.
116. Whelan JG III and Vlahos NF. The ovarian hyperstimulation syndrome. Fertility and Sterility 2000; 73: 883-96.
117. Wilton L, Voullaire L, Sargeant P, Williamson R and McBain J. Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescent in situ hybridization of embryos from patients with recurrent implantation failure. Fertility and Sterility 2003; 80:860-8.
118. Zheng WT, Zhuang GL, Zhou CQ et al. Comparison of the survival of human biopsied embryos after cryopreservation with four different methods using non-transferable embryos. Human Reproduction 2005; 20:1615-18.